Ernexa Therapeutics (ERNA) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Ernexa Therapeutics (ERNA) over the last 13 years, with Q3 2025 value amounting to 0.01.
- Ernexa Therapeutics' Debt Ratio fell 9895.92% to 0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year decrease of 9895.92%. This contributed to the annual value of 0.13 for FY2022, which is N/A changed from last year.
- As of Q3 2025, Ernexa Therapeutics' Debt Ratio stood at 0.01, which was down 9895.92% from 0.01 recorded in Q2 2025.
- Ernexa Therapeutics' 5-year Debt Ratio high stood at 0.64 for Q3 2024, and its period low was 0.01 during Q2 2025.
- Its 5-year average for Debt Ratio is 0.12, with a median of 0.02 in 2021.
- Per our database at Business Quant, Ernexa Therapeutics' Debt Ratio tumbled by 8695.97% in 2021 and then tumbled by 9895.92% in 2025.
- Quarter analysis of 5 years shows Ernexa Therapeutics' Debt Ratio stood at 0.01 in 2021, then soared by 1174.85% to 0.13 in 2022, then grew by 25.61% to 0.17 in 2023, then surged by 282.95% to 0.64 in 2024, then plummeted by 98.96% to 0.01 in 2025.
- Its Debt Ratio was 0.01 in Q3 2025, compared to 0.01 in Q2 2025 and 0.64 in Q3 2024.